By Anonymous (not verified), 10 February, 2025 Neuland Labs has been recognised as the ‘Top Value Creator’ in the Pharmaceutical Industry by Dun & Bradstreet India for delivering long-term value to all their stakeholders beyond financial growth
By Anonymous (not verified), 16 December, 2024 Neuland Labs has been honoured with the prestigious Sword of Honour by the British Safety Council
By Anonymous (not verified), 14 November, 2024 The Essential Role of Intellectual Property Expertise in a Pharmaceutical API Company
By Anonymous (not verified), 30 October, 2024 Securing Sustainability Throughout the Pharmaceutical Supply Chain SUCHETH DAVULURI Vice Chairman and CEO
By Anonymous (not verified), 28 October, 2024 Defining New Rules - The Evolution of the CDMO Industry Expert Statement: Saharsh Davuluri, Vice Chairman and MD
By Anonymous (not verified), 3 October, 2024 Achieving Drug Development Success: Inside Neuland’s Three-Pillar Project Management Strategy
By Anonymous (not verified), 2 September, 2024 Neuland Labs' Manufacturing Unit III Facility secured a Five Star Safety Rating with an audit score of 92.29% from the British Safety Council
By Anonymous (not verified), 22 August, 2024 Neuland Labs' Manufacturing Unit II Facility achieved a Five Star Safety Rating with an audit score of 92.20% from the British Safety Council
By Anonymous (not verified), 2 August, 2024 Zero Liquid Discharge: A Pharma Industry Commitment to Environmental Sustainability